MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash$5,028K Prepaid expenses andother current assets$783K Due from relatedparty$83K Total current assets$5,894K Right-of-use assets -operating leases, net$314K Property and equipment,net$82K Other assets$25K Total assets$6,315K Total liabilities andstockholders equity$6,315K Total stockholdersequity$3,200K Total liabilities$3,115K Accumulated deficit-$255,159K Additional paid-in capital$258,352K Total currentliabilities$2,932K Operating leaseliabilities, non-current$182K Other liabilities$1K Common stock, 0.005 parvalue, 150,000 shares...$6K Preferred stock, 0.005 parvalue, 1,000 shares...$1K Accounts payable$1,375K Accrued expenses$1,016K Due to related party$250K Operating leaseliabilities, current$167K Other currentliabilities$124K
Balance Sheet

Ernexa Therapeutics Inc. (ERNAW)

Ernexa Therapeutics Inc. (ERNAW)

source: myfinsight.com